Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific Snaps Up Dharmacon for $80M

NEW YORK, Feb. 12 (GenomeWeb News) - Bio-research supplier Fisher Scientific International will acquire RNAi provider Dharmacon for $80 million in cash, the companies said yesterday.


Dharmacon provides small interfering RNA technology and products. The company expects Fisher Scientific to maintain its facilities in Lafayette, Colo. Its shareholders will receive cash for all outstanding shares and option.


Fisher expects the acquisition, which has been approved by the boards of directors of both companies, to close by the end of March.


The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.